Composition for inducing transdifferentiation and stem cells treated therewith
AssigneeYj Cerapeutics Inc.
InventorsTae Young YUNE, Jee Youn LEE
Life of this patent
Estimating the term…
Loading patent…
AssigneeYj Cerapeutics Inc.
InventorsTae Young YUNE, Jee Youn LEE
Estimating the term…
The present invention relates to a composition for inducing direct conversion through oligomerization of CtBPs, and uses of stem cells treated therewith. Since the compounds of the present invention can induce transdifferentiation of adult stem cells into neural progenitor cells by regulating the oligomerization of CtBPs, the compounds can be used for inducing oligomerization of CtBPs or direct conversion. In addition, since ciNSC5 derived from direct conversion exhibits remarkable therapeutic effects in an ALS mouse model, an MS mouse model, a PD rat model, and a chronic spinal cord injury rat model, ciNSC5 can be used as a cellular therapeutic agent.
A method for inducing oligomerization of C-terminal Binding Proteins (CtBPs), comprising treating a sample in vitro with at least one selected from the group consisting of a compound of Chemical Formula 1, a compound of Chemical Formula 2, and a compound of Chemical Formula 3:
3-11. (canceled)
(canceled)
15-18. (canceled)
A method for inducing direct conversion of adult stem cells into neural progenitor cells, comprising treating adult stem cells with at least one selected from the group consisting of a compound of Chemical Formula 1, a compound of Chemical Formula 2, and a compound of Chemical Formula 3 in vitro,
Stem cells treated with at least one compound selected from the group consisting of a compound of Chemical Formula 1, a compound of Chemical Formula 2, and a compound of Chemical Formula 3 below:
(canceled)
(canceled)
37-45. (canceled)
Dependencies are inferred from the claim text.